Duffy‐null erythrocyte phenotype and the risk of thrombotic events in essential thrombocythemia

Duffy‐null erythrocyte phenotype and the risk of thrombotic events in essential thrombocythemia

Bibliographic Details
Main Authors:	Ivan Krecak, Marko Lucijanic
Format:	Article
Language:	English
Published:	Wiley 2023-11-01
Series:	eJHaem
Online Access:	https://doi.org/10.1002/jha2.773

Similar Items

THROMBOTIC AND BLEEDING RISK FACTORS IN ESSENTIAL THROMBOCYTHEMIA
by: A. A. Zhernyakova, et al.
Published: (2017-06-01)

Acute thrombotic complication of essential thrombocythemia
by: Selami Koçak Toprak, et al.
Published: (2011-12-01)

Acute thrombotic complication of essential thrombocythemia in a young adult
by: Selami Koçak Toprak, et al.
Published: (2011-12-01)

Invisible Infrastructure in Haematology: Neutrophil Reference Ranges and the Duffy-null Phenotype
by: Lauren E. Merz, et al.
Published: (2023-11-01)

PB2241: THE VASCULAR RISK OF ESSENTIAL THROMBOCYTHEMIA AND RELIABILITY OF THROMBOTIC RISK ASSESSMENT SCORES
by: Arij Cheffai, et al.
Published: (2023-08-01)

PB2201: ASSOCIATION OF HIGH PLATELETCRIT WITH THROMBOTIC RISK IN POLYCYTHEMIA VERA DEPENDS ON HEMATOCRIT AND LEUKOCYTE COUNT
by: Ivan Krecak, et al.
Published: (2023-08-01)

Essential thrombocythemia
by: Brière Jean B
Published: (2007-01-01)

PB2188: PROTON PUMP INHIBITORS ARE SAFE AND EFFECTIVE IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA VERA TREATED WITH LOW-DOSE ASPIRIN
by: Ivan Krecak, et al.
Published: (2023-08-01)

The Association Between Gene Polymorphisms and Leukocytosis with Thrombotic Complications in Patients with Essential Thrombocythemia and Polycythemia Vera
by: Özgür Mehtap, et al.
Published: (2012-05-01)

Impact of JAK2V617F mutational on haematologic features in Sudanese patients with essential thrombocythemia and thrombotic risk assessment
by: Elbager, Sahar G., et al.
Published: (2020)

Reduced Plasmodium vivax erythrocyte infection in PNG Duffy-negative heterozygotes.
by: Laurin J Kasehagen, et al.
Published: (2007-03-01)

Neuromyotonia in association with essential thrombocythemia.
by: Benito-León, J, et al.
Published: (2000)

Ruxolitinib for the Treatment of Essential Thrombocythemia
by: Arief Gunawan, et al.
Published: (2018-08-01)

Essential Thrombocythemia in Children and Adolescents
by: Maria Caterina Putti, et al.
Published: (2021-12-01)

MODALITY OF TREATMENT IN ESSENTIAL THROMBOCYTHEMIA
by: Lana Macukanovic-Golubovic, et al.
Published: (2008-10-01)

Emerging treatments for essential thrombocythemia
by: Okoli S, et al.
Published: (2011-12-01)

Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia.
by: Harrison, C, et al.
Published: (2005)

Low-Risk Essential Thrombocythemia: A Comprehensive Review
by: Andrew J. Robinson, et al.
Published: (2021-02-01)

Thrombotic thrombocytopenic purpura in a patient on long-term alpha-interferon therapy for essential thrombocythemia: a case report
by: Chunmei Qin, et al.
Published: (2023-05-01)

Polypharmacy, Potentially Inappropriate Medications, and Drug-to-Drug Interactions in Patients with Chronic Myeloproliferative Neoplasms
by: Ivan Krečak, et al.
Published: (2023-04-01)

Moyamoya syndrome in an adult with essential thrombocythemia
by: Marc Lazzaro, et al.
Published: (2011-04-01)

Essential thrombocythemia: Rare cause of chorea
by: Eswaradass Prasanna Venkatesan, et al.
Published: (2014-01-01)

Essential thrombocythemia presenting as digital ischemia
by: Md. Nazmul Hasan, et al.
Published: (2017-09-01)

The molecular profile in patients with polycythemia vera and essential thrombocythemia is dynamic and correlates with disease’s phenotype
by: Patryk Sobieralski, et al.
Published: (2023-08-01)

Increased von Willebrand factor levels in polycythemia vera and phenotypic differences with essential thrombocythemia
by: Monica Sacco, et al.
Published: (2020-03-01)

PB2192: JAK2 V617F ALLELE BURDEN AND THROMBOTIC EVENTS IN PATIENTS WITH JAK2 V617F POSITIVE POLYCYTHEMIA VERA OR ESSENTIAL THROMBOCYTHEMIA AT HIGH RISK OF THROMBOSIS
by: Yun Hui Hwang, et al.
Published: (2023-08-01)

PB2214: CORRELATION BETWEEN HEMORRHAGIC EVENTS AND IPSET SCORE IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA
by: Luca Tosoni, et al.
Published: (2023-08-01)

Erythrocyte-binding assays reveal higher binding of Plasmodium knowlesi Duffy binding protein to human Fya+/b+ erythrocytes than to Fya+/b- erythrocytes
by: Mun Yik Fong, et al.
Published: (2018-09-01)

Erythrocyte-binding assays reveal higher binding of Plasmodium knowlesi Duffy binding protein to human Fya+/b+ erythrocytes than to Fya+/b- erythrocytes
by: Fong, Mun Yik, et al.
Published: (2018)

Pregnancy with Essential Thrombocythemia: A Case Report
by: Yin-Jou Chou, et al.
Published: (2004-12-01)

Thiol-disulphide homeostasis in essential thrombocythemia patients
by: Sentürk-Yikilmaz Aysun, et al.
Published: (2019-01-01)

Generalized granuloma annulare associated with essential thrombocythemia
by: Sai P. Polineni, et al.
Published: (2020-06-01)

Updates in the management of polycythemia vera and essential thrombocythemia
by: Prithviraj Bose, et al.
Published: (2019-08-01)

Essential thrombocythemia manifesting as ophthalmic artery occlusion
by: Kittipong Thabsuwan, et al.
Published: (2020-06-01)

Correction Notice: Low-risk Essential Thrombocythemia: A Comprehensive Review
Published: (2022-02-01)

Neutrophil Effector Functions Are Not Impaired in Duffy Antigen Receptor for Chemokines (DARC)-Null Black South Africans
by: Kewreshini K. Naidoo, et al.
Published: (2019-03-01)

P1040: HIGHER ESTIMATED PLASMA VOLUME STATUS IS ASSOCIATED WITH INCREASED THROMBOTIC RISK AND IMPAIRED SURVIVAL IN PATIENTS WITH PRIMARY MYELOFIBROSIS
by: M. Lucijanic, et al.
Published: (2022-06-01)

Diversity pattern of Duffy binding protein sequence among Duffy-negatives and Duffy-positives in Sudan
by: Mohammad Rafiul Hoque, et al.
Published: (2018-08-01)

PB2219: POLYPHARMACY AND DRUG-TO-DRUG INTERACTIONS MAY HAVE A NEGATIVE EFFECT ON SURVIVAL IN PATIENTS WITH CHRONIC MYELOPROLIFERATIVE NEOPLASMS
by: Ivan Krecak, et al.
Published: (2023-08-01)

Plasmodium vivax invasion of human erythrocytes inhibited by antibodies directed against the Duffy binding protein.
by: Brian T Grimberg, et al.
Published: (2007-12-01)